http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0001353-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P10-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0812
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C22B15-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C22B15-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D419-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22B3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
filingDate 2000-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4135bf4baee57f3ab31c597afcc69c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b6a85e3441c885b6cb9ab0f2cf61fbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d951e10900be7ef2d5c25121b64c98da
publicationDate 2001-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0001353-A2
titleOfInvention Process for the preparation of quinazoline derivatives having anticancer activity and intermediates of the process
abstract The present invention relates to a novel process for the preparation of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 and R 2 are independently alkyl or alkoxy, wherein said alkyl or alkoxy may be optionally substituted with up to two substituents; R 15 is hydrogen, alkyl, or - (CH 2) q - (C 6 -C 10) aryl, wherein q is an integer from 0 to 9. In the process, a compound of formula (II) wherein R1, R2 and R15 are as defined for compounds of formula (I) and G is a blocking group of the formula -C (OH) R3R4 or -SiR3R4R5, R3, R4 and R5 are each is independently alkyl, (a) reacting a alkali metal or alkaline earth metal with a hydroxide in a solvent containing a hydroxy substituted subgroup, wherein G is -C (OH) R 3 R 4, or (b) a tetra- (C 1 -C 6) alkylammonium. reaction with a fluoride compound in an aprotic solvent wherein G is -SiR3R4R5. The invention also relates to intermediates of formula (II). SHE
priorityDate 1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 56.